Skip to main content

phentolamine

Generic: PHENTOLAMINE MESYLATE·Brand: ORAVERSE, OraVerse, PHENTOLAMINE MESYLATE, REGITINE, RYZUMVI, Ryzumvi

phentolamine: developed by 1 company · 1 FDA decision.

phentolamine evidence translation

What we can confirm

What it means

Source-backed records connect phentolamine to DTIL; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could phentolamine → DTIL affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Development Pipeline (1)
CompanyPhase
PRECISION BIOSCIENCES INC (DTIL)Approved
FDA Decisions1 records
ApprovalINDICATIONS AND USAGE Phentolamine Mesylate for Injection, USP is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. Phentolamine Mesylate for Injection, USP is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. Phentolamine Mesylate for Injectio(DTIL)FDA ↗
ANDA207686UNKNOWNStandardOtherInjectable

Frequently asked questions

Who is developing phentolamine?

phentolamine is being developed by PRECISION BIOSCIENCES INC.

What is phentolamine's latest FDA decision?

The most recent tracked FDA decision for phentolamine is Approval for INDICATIONS AND USAGE Phentolamine Mesylate for Injection, USP is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. Phentolamine Mesylate for Injection, USP is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. Phentolamine Mesylate for Injectio, dated July 14, 2017.